Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

23Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Diquafosol is a P2Y2 receptor agonist that has been shown to be effective in the treatment of dry eye disease (DED) in short-term studies; however, its long-term safety and effectiveness have not been evaluated in a real-world setting. Methods: This prospective, multicentre, open-label observational study was conducted in patients with DED over 12 months. Safety endpoints included the incidence of adverse drug reactions (ADRs) and serious ADRs. Effectiveness endpoints included change from baseline in keratoconjunctival staining score, tear film break-up time (BUT) and Dry Eye-related Quality of Life Score (DEQS). Results: A total of 580 patients were included, most of whom were female (82.9%). The proportion of patients who completed 12 months of observation was 55.0%, the most common reason for discontinuation was patient decision (54.6%). The incidence of ADRs was 10.7% and was highest during the first month of treatment (5.5%); no serious ADRs were reported. Compared with baseline, significant improvements in all effectiveness outcomes, including keratoconjunctival fluorescein staining score, BUT and DEQS summary score, were observed at each evaluation during the treatment period (p < 0.001). Conclusion: The present, real-world study showed that diquafosol 3.0% ophthalmic solution was well tolerated and effective in the long-term treatment of DED.

References Powered by Scopus

TFOS DEWS II Definition and Classification Report

2302Citations
N/AReaders
Get full text

TFOS DEWS II Diagnostic Methodology report

1473Citations
N/AReaders
Get full text

Observational research methods. Research design II: Cohort, cross sectional, and case-control studies

980Citations
N/AReaders
Get full text

Cited by Powered by Scopus

From purines to purinergic signalling: molecular functions and human diseases

264Citations
N/AReaders
Get full text

Neutrophils and neutrophil extracellular trap components: Emerging biomarkers and therapeutic targets for age-related eye diseases

22Citations
N/AReaders
Get full text

Improving ocular bioavailability of hydrophilic drugs through dynamic covalent complexation

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ohashi, Y., Munesue, M., Shimazaki, J., Takamura, E., Yokoi, N., Watanabe, H., … Shimada, F. (2020). Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study. Advances in Therapy, 37(2), 707–717. https://doi.org/10.1007/s12325-019-01188-x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

60%

Lecturer / Post doc 2

20%

Professor / Associate Prof. 1

10%

Researcher 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

64%

Nursing and Health Professions 2

14%

Agricultural and Biological Sciences 2

14%

Pharmacology, Toxicology and Pharmaceut... 1

7%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 15

Save time finding and organizing research with Mendeley

Sign up for free